Please assess the completion status of the following clinical trial:

Trial Title: Continuous Positive Airway Pressure and Cardiometabolic Risk

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Body mass index greater than 95th percentile for age and gender~2. Moderate to severe obstructive sleep apnea (OSA) (as defined by an apnea-hypopnea index (AHI) score of ≥5 events per hour).~Only patients who provide informed assent or consent and also have consent from a parent will be included.~Exclusion Criteria:~1. Predominant central sleep apnea~2. Type 1 Diabetes~3. Type 2 Diabetes~4. Requires use of supplemental oxygen~5. Active infection, cancer, or chronic inflammatory disorder~6. Use of systemic steroids~7. Simultaneous use of peroxisome proliferator-activated receptor (PPAR)-alpha (e.g., gemfibrozil, fenofibrate) or PPAR-gamma (e.g., rosiglitazone, pioglitazone)

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- CPAP/Bi-PAP (Type: EXPERIMENTAL): Subjects will be treated with either CPAP or Bi-PAP for three months.

Based on this trial design, predict the completion outcome and termination type (if applicable).